Niagen Bioscience

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$31,474
$33,839
$33,986
$31,117
Gross Profit
19,976
21,704
21,928
20,226
EBITDA
1,867
2,967
4,995
3,540
EBIT
1,576
2,103
4,800
3,185
Net Income
6,318
4,131
4,578
3,609
Net Change In Cash
31,474
33,839
33,986
31,117
Free Cash Flow
-1,255
523
3,668
1,115
Cash
66,549
64,788
64,138
60,322
Basic Shares
84,566
84,444
86,619
86,241

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$129,423
$99,597
$83,570
$72,050
Gross Profit
83,189
61,586
50,780
42,797
EBITDA
15,746
9,210
-3,894
-16,744
EBIT
14,296
7,726
-5,599
-18,628
Net Income
17,382
8,550
-4,938
-16,540
Net Change In Cash
129,423
99,597
83,570
72,050
Free Cash Flow
13,145
11,946
6,969
-15,432
Cash
64,788
44,508
27,173
20,289
Basic Shares
85,436
79,724
74,985
69,729

Earnings Calls

QuarterEPS
2026-03-31
$0.07
2025-12-31
$0.02
2025-09-30
$0.05
2025-06-30
$0.04